The FDA sent a warning letter this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, potential side effects in patients who took its popular medications containing semiglutide.
FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects
Related Posts
-
Need holiday gift inspiration? Here are four affordable picks from Oprah’s Favorite Things
Oprah Daily shares cozy, creative and space-saving picks for holiday shoppers.
-
Former Mitchellville city employee sues for defamation after alleged threat
The former mayor of Mitchellville and his wife are accused of defaming a former city…
-
Microsoft confirms Outlook outage affecting users worldwide
Thousands of users reported issues using Microsoft Outlook Thursday afternoon.
-
Wetter-than-average October brings drought-free conditions to Iowa
DES MOINES, Iowa — The latest information from the U.S. Drought Monitor, released on Thursday,…
Leave a Reply